TRT dangers and benefits: what the evidence actually shows
Quick answer
TRT is an FDA-regulated treatment indicated for men with confirmed hypogonadism, characterized by low serum testosterone combined with clinical symptoms such as reduced libido, fatigue, and depressed mood. The side effects described in the video, including infertility, testicular atrophy, polycythemia, and gynecomastia, are documented in clinical literature and require ongoing monitoring by a prescribing clinician. The cardiovascular risk picture has become more nuanced following the 2023 TRAVERSE trial, which found no significant increase in major adverse cardiac events in appropriately selected patients.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @patrickspicks77 actually say?
The creator opened with a statistic: a "300% increase in men taking TRT between 2001 and 2013," followed by a claim that usage has since dropped because men are "now educated on the negative effects." He then listed benefits including improved libido, stamina, sleep, and mood, before running through a side-effect list: infertility, testicular atrophy, gynecomastia, hair loss, acne, blood clots, heart disease, and stroke. He closed by steering viewers toward "natural" testosterone-boosting supplements and lifestyle changes instead of TRT.
The video attempts balance, which is more than most TRT content on TikTok tries to do. But the framing is shaky in a few places, and the pivot to herbal supplements at the end raises some questions worth addressing.
Does the science back this up?
Mostly, yes, on the side effects. No, on the decline narrative. The side-effect list is broadly consistent with prescribing literature and regulatory warnings, but the claim that TRT declined because men got educated is not what the data shows.
The 300% growth figure is in the right ballpark. Baillargeon et al. (2013, JAMA Internal Medicine) documented a sharp rise in testosterone prescribing from 2001 onward, particularly in men without a confirmed hypogonadism diagnosis. The subsequent slowdown is better explained by the FDA's 2015 safety communication requiring cardiovascular risk labeling on all testosterone products, followed by prescriber caution, not some grassroots education movement. Attributing the decline to consumer awareness is a flattering narrative without supporting evidence.
On the cardiovascular side, the risk picture is genuinely complicated. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), the largest randomized trial of TRT to date, found no significant increase in major adverse cardiovascular events in men with hypogonadism and existing cardiovascular risk. That does not mean TRT is risk-free, but it does mean the "increases your risk of heart disease and stroke" claim deserves more nuance than a quick mention in a list.
What did they get wrong (or right)?
Credit where it is due: the fertility warning is accurate and consistently underemphasized in pro-TRT content. TRT suppresses the hypothalamic-pituitary-gonadal axis, which sharply reduces sperm production. Saying "stay far, far away" if you are trying to conceive is the right call.
Testicular atrophy and gynecomastia are real and documented. Gynecomastia occurs through aromatization of exogenous testosterone to estradiol. Hair loss and acne depend heavily on individual androgen sensitivity, so the framing as universal risks overstates things a bit.
What he got wrong is the blood clot framing. Polycythemia, meaning elevated red blood cell count from TRT, does increase clotting risk, particularly in men who are already at risk or using high doses. But presenting clots alongside heart disease and stroke as equally likely outcomes misses the mechanism and the patient-specific nature of that risk.
The biggest problem is the ending. Pivoting from legitimate medical therapy to "herbal supplements" and "testosterone-boosting supplements" as if those are validated alternatives is not supported by clinical evidence. There is no supplement with a comparable evidence base to TRT for treating diagnosed hypogonadism.
What should you actually know?
TRT is a regulated medical therapy with a real evidence base for men with clinically confirmed low testosterone, typically defined as total testosterone below 300 ng/dL with symptoms. It is not a wellness upgrade for men in the normal range, and it is not something herbal supplements can replicate for men with actual hypogonadism.
The TRAVERSE trial data from 2023 changed the cardiovascular conversation. For appropriately screened patients, the blanket "causes heart disease" claim is harder to sustain than it was in 2015 when the FDA first issued warnings. That does not mean TRT is safe for everyone. Polycythemia, infertility, and gynecomastia remain real clinical considerations that require monitoring, not just a disclaimer at the end of a TikTok video.
If a creator is pushing you toward supplement stacks as a TRT alternative without citing clinical trial data on those specific supplements, treat that recommendation skeptically. Zinc, vitamin D, and ashwagandha show modest effects in men who are genuinely deficient, but none of them replicate the effect size of actual testosterone replacement in hypogonadal men. Anyone managing actual low testosterone should be working with a licensed clinician, not following a supplement protocol from social media.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT dangers and benefits: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT dangers and benefits: what the evidence actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
TRT is an FDA-regulated treatment indicated for men with confirmed hypogonadism, characterized by low serum testosterone combined with clinical symptoms such as reduced libido, fatigue, and depressed mood.
FormBlends verdict
TRT is an FDA-regulated treatment indicated for men with confirmed hypogonadism, characterized by low serum testosterone combined with clinical symptoms such as reduced libido, fatigue, and depressed mood. The side effects described in the video, including infertility, testicular atrophy, polycythemia, and gynecomastia, are documented in clinical literature and require ongoing monitoring by a prescribing clinician. The cardiovascular risk picture has become more nuanced following the 2023 TRAVERSE trial, which found no significant increase in major adverse cardiac events in appropriately selected patients.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- TRT is an FDA-regulated treatment indicated for men with confirmed hypogonadism, characterized by low serum testosterone combined with clinical symptoms such as reduced libido, fatigue, and depressed mood. The side effects described in the video, including infertility, testicular atrophy, polycythemia, and gynecomastia, are documented in clinical literature and require ongoing monitoring by a prescribing clinician. The cardiovascular risk picture has become more nuanced following the 2023 TRAVERSE trial, which found no significant increase in major adverse cardiac events in appropriately selected patients.
- The FDA issued a 2015 safety communication requiring cardiovascular risk warnings on all testosterone products, which is a more documented explanation for prescribing slowdowns than consumer education alone.
- The 2023 TRAVERSE trial (Lincoff et al., New England Journal of Medicine) found no significant increase in major adverse cardiac events in hypogonadal men on TRT, which meaningfully updates older cardiovascular risk claims.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The FDA issued a 2015 safety communication requiring cardiovascular risk warnings on all testosterone products, which is a more documented explanation for prescribing slowdowns than consumer education alone.
- The 2023 TRAVERSE trial (Lincoff et al., New England Journal of Medicine) found no significant increase in major adverse cardiac events in hypogonadal men on TRT, which meaningfully updates older cardiovascular risk claims.
- TRT reliably suppresses spermatogenesis by reducing LH and FSH, making the fertility warning one of the most clinically important points in the video and one that is frequently missed in pro-TRT content.
- Testicular atrophy and gynecomastia are real, documented side effects requiring monitoring, but hair loss and acne are highly dependent on individual androgen receptor sensitivity and are not universal outcomes.
- No commercially available supplement has an evidence base that makes it a valid substitute for TRT in men with confirmed hypogonadism, defined clinically as total testosterone below 300 ng/dL with symptoms.
- Polycythemia, elevated red blood cell count driven by testosterone, is the primary mechanism behind TRT-associated clotting risk and is a manageable but real concern that requires regular hematocrit monitoring.
- TRT is indicated for diagnosed hypogonadism, not general wellness optimization, and any treatment decision should involve lab-confirmed hormone levels and evaluation by a licensed clinician.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Patrick’s Picks · TikTok creator
8.1K views on this video
Dangers of TRT. I explore both the GOOD and the BAD. #trt #testosterone #libidoboosting #vitality #healthhacks
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Patrick’s Picks, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.